These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2912183)

  • 21. The role of lipid mediators in hypoxic pulmonary vasoconstriction in newborns.
    Bradley LM; Feuerstein G; Goldstein RE
    Prog Clin Biol Res; 1989; 301():247-52. PubMed ID: 2798449
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of prostaglandins and PG-analogues on the mortality of PAF-acether in mice and the TXB2 release from human granulocytes.
    Becker K; Förster W
    Biomed Biochim Acta; 1988; 47(10-11):S169-72. PubMed ID: 3248104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of leukotrienes in the late hemodynamic manifestations of group B streptococcal sepsis in piglets.
    Goldberg RN; Suguihara C; Martinez O; Bancalari A; Clark MR; Bancalari E
    Prostaglandins Leukot Essent Fatty Acids; 1988 Sep; 33(3):191-8. PubMed ID: 3054937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-activating factor modulates pulmonary vasomotor tone in the perinatal lamb.
    Ibe BO; Hibler S; Raj JU
    J Appl Physiol (1985); 1998 Sep; 85(3):1079-85. PubMed ID: 9729586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Putative mechanism of hypotensive action of platelet-activating factor in dogs.
    Yamanaka S; Miura K; Yukimura T; Okumura M; Yamamoto K
    Circ Res; 1992 May; 70(5):893-901. PubMed ID: 1568300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig.
    Ezra D; Laurindo FR; Czaja JF; Snyder F; Goldstein RE; Feuerstein G
    Prostaglandins; 1987 Jul; 34(1):41-57. PubMed ID: 3685397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of hypotension produced by platelet-activating factor.
    Laurindo FR; Goldstein RE; Davenport NJ; Ezra D; Feuerstein GZ
    J Appl Physiol (1985); 1989 Jun; 66(6):2681-90. PubMed ID: 2745330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute microvascular effects of PAF-acether, as studied by intravital microscopy.
    Björk J; Smedegård G
    Eur J Pharmacol; 1983 Dec; 96(1-2):87-94. PubMed ID: 6662199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exudative, cellular and humoral reactions to platelet-activating factor (PAF-acether) in the pleural cavity of rats.
    Tarayre JP; Delhon A; Bruniquel F; Puech L; Tisne-Versailles J; Couzinier JP
    Eur J Pharmacol; 1986 May; 124(3):317-23. PubMed ID: 3755401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
    Cattaneo M; Canciani MT; Mannucci PM
    Thromb Haemost; 1985 Apr; 53(2):221-4. PubMed ID: 3927505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils.
    Pirotzky E; Page CP; Roubin R; Pfister A; Paul W; Bonnet J; Benveniste J
    Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):107-22. PubMed ID: 6546141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-activating factor: evidence against a role in hypoxic pulmonary vasoconstriction.
    McCormack DG; Barnes PJ; Evans TW
    Crit Care Med; 1990 Dec; 18(12):1398-402. PubMed ID: 2245615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo.
    Darius H; Smith JB; Lefer AM
    J Pharmacol Exp Ther; 1985 Nov; 235(2):274-81. PubMed ID: 2997428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular changes in group B streptococcal sepsis in the piglet: response to indomethacin and relationship to prostacyclin and thromboxane A2.
    Runkle B; Goldberg RN; Streitfeld MM; Clark MR; Buron E; Setzer ES; Bancalari E
    Pediatr Res; 1984 Sep; 18(9):874-8. PubMed ID: 6384909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection.
    Pretolani M; Lefort J; Vargaftig BB
    Am Rev Respir Dis; 1988 Dec; 138(6):1572-8. PubMed ID: 3202509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic effects of PAF-acether.
    Plante GE; Hebert RL; Lamoureux C; Braquet P; Sirois P
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():173-9. PubMed ID: 3774843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboxane mediates the renal hemodynamic effects of platelet activating factor.
    Yoo J; Schlondorff D; Neugarten J
    J Pharmacol Exp Ther; 1990 May; 253(2):743-8. PubMed ID: 2140130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute lung injury in endotoxemic pigs: role of leukotriene B4.
    VanderMeer TJ; Menconi MJ; O'Sullivan BP; Larkin VA; Wang H; Sofia M; Fink MP
    J Appl Physiol (1985); 1995 Mar; 78(3):1121-31. PubMed ID: 7775306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BB-882 is a potent antagonist of the haemodynamic changes induced by platelet-activating factor in pigs.
    Abu-Zidan FM; Walther S; Lennquist S
    Pharmacol Toxicol; 1996 Jan; 78(1):23-7. PubMed ID: 8685082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostanoids: early mediators in the secondary injury that develops after unilateral pulmonary contusion.
    Davis KA; Fabian TC; Croce MA; Proctor KG
    J Trauma; 1999 May; 46(5):824-31; discussion 831-2. PubMed ID: 10338399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.